# Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases

> **NCT06871644** · NA · NOT_YET_RECRUITING · sponsor: **PersonGen BioTherapeutics (Suzhou) Co., Ltd.** · enrollment: 18 (estimated)

## Conditions studied

- Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria

## Interventions

- **BIOLOGICAL:** T cell injection targeting CD7 chimeric antigen receptor

## Key facts

- **NCT ID:** NCT06871644
- **Lead sponsor:** PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-18
- **Primary completion:** 2026-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06871644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06871644, "Clinical Study of CD7 CAR-T Cells for Relapsed/refractory Autoimmune Diseases". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06871644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*